ESC Premium Access

Effects of atrial fibrillation ablation in patients with stroke risk factors: the CABANA Trial.

Congress Presentation

About the speaker

Doctor Douglas L Packer

901 Kaito Lane, Rochester (United States of America)
16 presentations
1 follower

3 more presentations in this session

Effects of atrial fibrillation ablation in patients with lV dysfunction: the CASTE-AF trial.

Speaker: Professor J. Brachmann (Coburg, DE)


Critical appraisal of the CABANA and CASTLE-AF trials.

Speaker: Professor I. Van Gelder (Groningen, NL)


Will the technical improvements in atrial fibrillation ablation further improve the success of atrial fibrillation ablation.

Speaker: Professor G. Hindricks (Berlin, DE)


Access the full session

Is atrial fibrillation ablation a mature treatment to reduce morbi-mortality?

Speakers: Doctor D. Packer, Professor J. Brachmann, Professor I. Van Gelder, Professor G. Hindricks

About the event


ESC Congress 2018

7 November - 29 August 2018

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb